These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9719812)

  • 1. The biotechnology revolution and world health.
    Nossal SG
    Public Health Rep; 1998; 113(2):122-7. PubMed ID: 9719812
    [No Abstract]   [Full Text] [Related]  

  • 2. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotechnology and the developing world. Finding ways to bridge the agricultural technology gap.
    Platais KW; Collinson MP
    Finance Dev; 1992 Mar; ():34-6. PubMed ID: 12284926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases.
    Hentschel CC
    Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS. Resource needs for HIV/AIDS.
    Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
    Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners.
    Coloma J; Harris E
    Ann N Y Acad Sci; 2008; 1136():358-68. PubMed ID: 17954678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized medicine and the imperative of global health.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2007 Nov; 82(5):479-83. PubMed ID: 17952097
    [No Abstract]   [Full Text] [Related]  

  • 8. Public-private partnerships for health: their main targets, their diversity, and their future directions.
    Widdus R
    Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global health public-private partnerships: IAVI, partnerships and capacity building.
    Hanlin R; Chataway J; Smith J
    Afr J Med Med Sci; 2007; 36 Suppl():69-75. PubMed ID: 17703568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of biomedical research resources and international justice.
    Resnik DB
    Dev World Bioeth; 2004 May; 4(1):42-57. PubMed ID: 15086373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are today's orphaned vaccines?
    Wilde H
    Clin Infect Dis; 2001 Sep; 33(5):648-50. PubMed ID: 11486287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting the challenge of antibiotic resistance.
    Cars O; Högberg LD; Murray M; Nordberg O; Sivaraman S; Lundborg CS; So AD; Tomson G
    BMJ; 2008 Sep; 337():a1438. PubMed ID: 18801866
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms for collaboration between public and private veterinarians: the animal health accreditation mandate.
    Le Brun Y
    Rev Sci Tech; 2004 Apr; 23(1):69-77, 59-68; discussion 391-401. PubMed ID: 15200087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health. Public-private partnerships and scientific imperialism.
    Tucker TJ; Makgoba MW
    Science; 2008 May; 320(5879):1016-7. PubMed ID: 18497279
    [No Abstract]   [Full Text] [Related]  

  • 15. Technological and social innovation: a unifying new paradigm for global health.
    Gardner CA; Acharya T; Yach D
    Health Aff (Millwood); 2007; 26(4):1052-61. PubMed ID: 17630448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Round table. A role for public-private partnerships in controlling neglected diseases?
    Ridley RG; Lob-Levyt J; Sachs J; Johns D; Evans T; Bale HE; Quick JD; Orbinski J
    Bull World Health Organ; 2001; 79(8):771-7. PubMed ID: 11545335
    [No Abstract]   [Full Text] [Related]  

  • 17. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 18. Cooperation forms to accelerate access to AIDS care in developing countries.
    AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881360
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world.
    Hale VG; Woo K; Lipton HL
    Health Aff (Millwood); 2005; 24(4):1057-63. PubMed ID: 16012146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.